142 related articles for article (PubMed ID: 32069516)
1. Effect of postdose fasting duration on hetrombopag olamine pharmacokinetics and pharmacodynamics in healthy volunteers.
Yang G; Huang R; Yang S; Zhang X; Yang X; Chen H; Huang Z; Guo C; Pei Q; Tai Y; Shen Y; Huang J; Zou C
Br J Clin Pharmacol; 2020 Aug; 86(8):1528-1536. PubMed ID: 32069516
[TBL] [Abstract][Full Text] [Related]
2. Effect of Food on the Pharmacokinetic and Pharmacodynamic Profiles of Hetrombopag in Healthy Volunteers.
Wang Z; Chen X; Li A; Chen L; Wang Y; Zheng L
Clin Ther; 2020 Dec; 42(12):2280-2288. PubMed ID: 33109386
[TBL] [Abstract][Full Text] [Related]
3. Safety, Pharmacokinetics and Pharmacodynamics of Hetrombopag Olamine, a Novel TPO-R Agonist, in Healthy Individuals.
Zheng L; Liang MZ; Zeng XL; Li CZ; Zhang YF; Chen XY; Zhu X; Xiang AB
Basic Clin Pharmacol Toxicol; 2017 Nov; 121(5):414-422. PubMed ID: 28544774
[TBL] [Abstract][Full Text] [Related]
4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
Chen C; Bujanover S; Kareht S; Rapoport AM
Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
[TBL] [Abstract][Full Text] [Related]
5. A phase 1, randomized, pharmacokinetic trial of the effect of different meal compositions, whole milk, and alcohol on cannabidiol exposure and safety in healthy subjects.
Crockett J; Critchley D; Tayo B; Berwaerts J; Morrison G
Epilepsia; 2020 Feb; 61(2):267-277. PubMed ID: 32012251
[TBL] [Abstract][Full Text] [Related]
6. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
[TBL] [Abstract][Full Text] [Related]
7. Impact of target-mediated drug disposition on hetrombopag pharmacokinetics and pharmacodynamics in Chinese healthy subjects and patients with chronic idiopathic thrombocytopenic purpura.
Wang Z; Zeng Z; Ye L; Zhu X; Pei Y; Wang Y; Zheng L
Br J Clin Pharmacol; 2022 May; 88(5):2084-2095. PubMed ID: 34705278
[TBL] [Abstract][Full Text] [Related]
8. A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
Mei H; Liu X; Li Y; Zhou H; Feng Y; Gao G; Cheng P; Huang R; Yang L; Hu J; Hou M; Yao Y; Liu L; Wang Y; Wu D; Zhang L; Zheng C; Shen X; Hu Q; Liu J; Jin J; Luo J; Zeng Y; Gao S; Zhang X; Zhou X; Shi Q; Xia R; Xie X; Jiang Z; Gao L; Bai Y; Li Y; Xiong J; Li R; Zou J; Niu T; Yang R; Hu Y
J Hematol Oncol; 2021 Feb; 14(1):37. PubMed ID: 33632264
[TBL] [Abstract][Full Text] [Related]
9. Effects of food and antacids on the pharmacokinetics of eltrombopag in healthy adult subjects: two single-dose, open-label, randomized-sequence, crossover studies.
Williams DD; Peng B; Bailey CK; Wire MB; Deng Y; Park JW; Collins DA; Kapsi SG; Jenkins JM
Clin Ther; 2009 Apr; 31(4):764-76. PubMed ID: 19446149
[TBL] [Abstract][Full Text] [Related]
10. Effect of a high-fat meal on the relative bioavailability of H3B-6527, a novel FGFR4 inhibitor, in healthy volunteers.
Rioux N; Kim A; Nix D; Bowser T; Warmuth M; Smith PG; Schindler J
Cancer Chemother Pharmacol; 2019 Jan; 83(1):91-96. PubMed ID: 30368584
[TBL] [Abstract][Full Text] [Related]
11. A phase I, single-sequence, open-label study to evaluate the drug-drug interaction between hetrombopag and cyclosporine in healthy Chinese subjects.
Li F; Lin H; Feng S; Cai L; Zhang L; Feng S; Liu X; Chen Z; Zou Q; Wu Y; Su X; Shen K; Yu Q
Br J Clin Pharmacol; 2023 Jul; 89(7):2160-2167. PubMed ID: 36654488
[TBL] [Abstract][Full Text] [Related]
12. First-in-patient study of hetrombopag in patients with chronic idiopathic thrombocytopenic purpura.
Wang Z; Chen L; Zhang F; Lu H; Chen X; Wen A; Luo J; Hu Y; Wang Y; Niu T; Zheng L
J Thromb Haemost; 2020 Nov; 18(11):3053-3060. PubMed ID: 32865293
[TBL] [Abstract][Full Text] [Related]
13. A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food.
Zomorodi K; Kankam M; Lu Y
Clin Ther; 2019 Feb; 41(2):196-204. PubMed ID: 30598342
[TBL] [Abstract][Full Text] [Related]
14. Effect of Food on the Bioavailability of Omadacycline in Healthy Participants.
Tzanis E; Manley A; Villano S; Tanaka SK; Bai S; Loh E
J Clin Pharmacol; 2017 Mar; 57(3):321-327. PubMed ID: 27539539
[TBL] [Abstract][Full Text] [Related]
15. Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension study.
Mei H; Liu X; Li Y; Zhou H; Feng Y; Gao G; Cheng P; Huang R; Yang L; Hu J; Hou M; Yao Y; Liu L; Wang Y; Wu D; Zhang L; Zheng C; Shen X; Hu Q; Liu J; Jin J; Luo J; Zeng Y; Gao S; Zhang X; Zhou X; Shi Q; Xia R; Xie X; Jiang Z; Gao L; Bai Y; Li Y; Xiong J; Li R; Zou J; Niu T; Yang R; Hu Y
J Thromb Haemost; 2022 Mar; 20(3):716-728. PubMed ID: 34821020
[TBL] [Abstract][Full Text] [Related]
16. The effect of different meal compositions on the oral bioavailability of treprostinil diolamine in healthy volunteers.
Lim A; Wang-Smith L; Kates J; Laurent A; Kumar P; Laliberte K
J Clin Pharm Ther; 2013 Dec; 38(6):450-5. PubMed ID: 23927483
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a New Amphetamine Extended-release Oral Liquid Suspension Under Fasted and Fed Conditions in Healthy Adults: A Randomized, Open-label, Single-dose, 3-treatment Study.
Sikes C; Stark JG; McMahen R; Engelking D
Clin Ther; 2017 Dec; 39(12):2389-2398. PubMed ID: 29174216
[TBL] [Abstract][Full Text] [Related]
18. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
[TBL] [Abstract][Full Text] [Related]
19. Hetrombopag: First Approval.
Syed YY
Drugs; 2021 Sep; 81(13):1581-1585. PubMed ID: 34357499
[TBL] [Abstract][Full Text] [Related]
20. Food Effect Study to Assess the Impact on Edaravone Pharmacokinetic Profiles in Healthy Participants.
Shimizu H; Nishimura Y; Shiide Y; Akimoto M; Matsuda H; Kato Y; Hirai M
Clin Ther; 2022 Dec; 44(12):1552-1565. PubMed ID: 36376130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
